IFPG
MRNA icon

Intrepid Financial Planning Group’s Moderna MRNA Stock Holding History

Intrepid Financial Planning Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,875
Closed -$223K – 132
2024
Q2 		$223K Buy
+1,875
New +$237K 0.1% 111
2023
Q3 		– Sell
-1,775
Closed -$216K – 124
2023
Q2 		$216K Hold
1,775
– – 0.1% 106
2023
Q1 		$273K Hold
1,775
– – 0.14% 91
2022
Q4 		$319K Hold
1,775
– – 0.17% 79
2022
Q3 		$210K Hold
1,775
– – 0.12% 92
2022
Q2 		$254K Buy
+1,775
New +$254K 0.14% 78

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Intrepid Financial Planning Group's MRNA Position: Q3 2024 in Review

Intrepid Financial Planning Group sold out of Moderna (MRNA) in Q3 2024, closing a stake of 1,875 shares — an estimated $223K sold.

Intrepid Financial Planning Group first reported a position in MRNA in Q2 2022 and held it in 6 quarters. The position peaked at $319K in Q4 2022. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Intrepid Financial Planning Group reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Intrepid Financial Planning Group sold 1,875 Moderna shares in Q3 2024, an estimated $223K.
  • Intrepid Financial Planning Group first reported a position in Moderna in Q2 2022 and held it in 6 quarters.
  • Intrepid Financial Planning Group's Moderna position peaked at $319K in Q4 2022.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Intrepid Financial Planning Group's 13F filing for Q3 2024, filed 4 Nov 2024.